Monoclonal antibody LS2D617
Latest Information Update: 03 Feb 1995
At a glance
- Originator Hybritech
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 03 Feb 1995 No-Development-Reported for Small cell lung cancer in USA (Unknown route)